175 related articles for article (PubMed ID: 34303763)
1. MiR-4310 regulates hepatocellular carcinoma growth and metastasis through lipid synthesis.
Li H; Chen Z; Zhang Y; Yuan P; Liu J; Ding L; Ye Q
Cancer Lett; 2021 Oct; 519():161-171. PubMed ID: 34303763
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-1251-5p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting AKAP12.
Han S; Wang L; Sun L; Wang Y; Yao B; Chen T; Liu R; Liu Q
Biomed Pharmacother; 2020 Feb; 122():109754. PubMed ID: 31918285
[TBL] [Abstract][Full Text] [Related]
3. MiR-3180 inhibits hepatocellular carcinoma growth and metastasis by targeting lipid synthesis and uptake.
Hong J; Liu J; Zhang Y; Ding L; Ye Q
Cancer Cell Int; 2023 Apr; 23(1):66. PubMed ID: 37041584
[TBL] [Abstract][Full Text] [Related]
4. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C
J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671
[TBL] [Abstract][Full Text] [Related]
5. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
Bai PS; Xia N; Sun H; Kong Y
J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
7. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
8. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S
Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of LncRNA ANRIL suppresses cell proliferation, metastasis, and invasion via regulating miR-122-5p expression in hepatocellular carcinoma.
Ma J; Li T; Han X; Yuan H
J Cancer Res Clin Oncol; 2018 Feb; 144(2):205-214. PubMed ID: 29127494
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-103 represses hepatic de novo lipogenesis and alleviates NAFLD via targeting FASN and SCD1.
Zhang M; Tang Y; Tang E; Lu W
Biochem Biophys Res Commun; 2020 Apr; 524(3):716-722. PubMed ID: 32035613
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
Zhang QY; Men CJ; Ding XW
J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
[TBL] [Abstract][Full Text] [Related]
12. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
[TBL] [Abstract][Full Text] [Related]
14. miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1.
Guo Y; Yu J; Wang C; Li K; Liu B; Du Y; Xiao F; Chen S; Guo F
J Mol Endocrinol; 2017 Oct; 59(3):205-217. PubMed ID: 28667176
[TBL] [Abstract][Full Text] [Related]
15. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-449 suppresses proliferation of hepatoma cell lines through blockade lipid metabolic pathway related to SIRT1.
Zhang H; Feng Z; Huang R; Xia Z; Xiang G; Zhang J
Int J Oncol; 2014 Nov; 45(5):2143-52. PubMed ID: 25119660
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
18. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway.
Zhao G; Dong L; Shi H; Li H; Lu X; Guo X; Wang J
Oncol Rep; 2016 Sep; 36(3):1709-16. PubMed ID: 27461404
[TBL] [Abstract][Full Text] [Related]
20. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]